Efficacy and Safety of the Angionix Balloon in Patients With Coronary Artery Disease Undergoing PTCA

A Multi-center, Registry evaluating the efficacy and safety of the use of Angionix Balloon in Patient with Coronary Artery Disease

Inclusion Criteria: 1. Adult aged 19 years or older at baseline 2. Patients diagnosed with coronary artery disease 3. Patients requiring percutaneous transluminal coronary angioplasty (PTCA) with Angionix Balloon or Angionix NC Balloon 4. Patients who voluntarily agree to participate in this study and sign an informed consent form Exclusion Criteria: 1. Patients presenting with cardiogenic shock based on the investigator's clinical judgment 2. Patients with vessel dissection already identified on coronary angiography prior to PTCA procedure based on the investigator's clinical judgment 3. Pregnant or lactating women 4. Patients who have other clinically significant findings that make them unsuitable for study participation based on the investigator's medical judgment